PURA Plans ‘To Disrupt’ $200 Billion Steel Rebar Market With Hemp Alternative
Puration, Inc. (OTC: PURA), a cannabis cultivation technology company, announced it "plans to disrupt the $200 billion steel rebar market with a hemp alternative".
Vegan Stocks Bolstered By Rising Interest In Textured Vegetable Protein Options
Initially invented and patented in the 1960s to extend ground meat as a means of reducing costs without reducing nutritional value, Textured Vegetable Proteins (TVPs) have recently received a huge boost from growing demand in plant-based protein options for vegetarians, vegans, and flexitarians,” reported FN Media Group in a
BioLife Sciences Inc. To Incorporate New Sub-Sector Dedicated To CBD
BioLife Sciences (OTCPK: BLFE), a firm dedicated to developing, licensing, and distributing antimicrobial products and disruptive technologies, announced on Tuesday that it is expanding its recently announced orthomolecular medicine and natural health products department to now include a subsector dedicated to non-psychoactive cannabinoids derived from industrial hemp, includin
Cara Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
Cara Therapeutics, Inc. (NASDAQ: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the fourth quarter and full year ended December 31, 2021.
Cannabis Company Xebra To Raise CAD$1.20M Via Private Placement
Cannabis company Xebra Brands Ltd. (CSE:XBRA) (OTCQB:XBRAF) (FSE: 9YC) plans to raise up to CAD$1.2 million via a non-brokered private placement.
22nd Century Group And KeyGene Achieve Breakthrough In Hemp/Cannabis GMO Research
22nd Century Group, Inc.
Cannabis Extraction Co. Ayurcann Shares Slightly Up On Record Sales, 106% YoY Revenue Growth
Cannabis extraction company, Ayurcann Holdings Corp. (CSE:AYUR) (OTCQB:AYURF) (FSE:3ZQ0) reported its financial and operating results for its second quarter ending December 31, 2021. All figures reported are in Canadian dollars.
Q2 Financial Summary
Tetra Bio-Pharma Signs License Agreement With Thorne Health Tech For A Prebiotic Dietary Supplement
Tetra Bio-Pharma Inc (TSX:TBP) (OTCQB: TBPMF) (FRA: JAM1), cannabinoid-based drug developer, has signed a licensing agreement with Thorne Health Tech, Inc. (NASDAQ: THRN) for the commercialization of its patent
Flowr Corp Sells Kelowna Research Facility To Hawthorne For $16M, Launches Four New Cannabis Strains
Flowr Corporation (TSXV:FLWR) (OTC:FLWPF) has agreed to sell its interest in the Kelowna Research Station R&D facility to Hawthorne Canada Limited for $16 million, to be paid as foll
